NCT00450138View on ClinicalTrials.gov

Open Label, Phase I ZD6474 Head and Neck Cancer Study

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2011

Conditions
Head and Neck Cancer
Interventions
DRUG

ZD6474 (vandetanib)

once daily oral dose

DRUG

Cisplatin

intravenous infusion

RADIATION

Radiation

radiation of head and neck

Trial Locations (4)

Unknown

Research Site, Denver

Research Site, Chicago

Research Site, Dallas

Research Site, Houston

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY